Raphael Pharmaceutical (RAPH) Current Assets (2020 - 2025)
Raphael Pharmaceutical (RAPH) reported Current Assets of $51000.0 for Q4 2025, up 104.0% on a YoY basis from $25000.0 in Q4 2024, and up 920.0% sequentially from $5000.0 in Q3 2025.
Raphael Pharmaceutical (RAPH) Current Assets (2020 - 2025) Analysis & Trends
Raphael Pharmaceutical (RAPH) has 6 years of Current Assets data on file, last reported at $51000.0 in Q4 2025.
- For the quarter ending Q4 2025, Current Assets rose 104.0% year-over-year to $51000.0; the trailing twelve-month figure through Dec 2025 stood at $51000.0 (up 104.0% YoY), and the FY2025 full-year result was $51000.0, up 104.0% from the prior year.
- Current Assets grew to $51000.0 in Q4 2025, from $5000.0 in the prior quarter.
- In the past five years, Current Assets ranged from a high of $422000.0 in Q4 2021 to a low of $5000.0 in Q3 2025.
- A 5-year average of $163388.9 and a median of $122500.0 in 2022 frame the typical range for Current Assets.
- Across the five-year window, Current Assets soared 237.82% in 2023 and plunged 89.8% in 2025, its largest moves.
- Tracing RAPH's Current Assets over 5 years: stood at $422000.0 in 2021, then fell by 21.56% to $331000.0 in 2022, then decreased by 28.4% to $237000.0 in 2023, then slumped by 89.45% to $25000.0 in 2024, then soared by 104.0% to $51000.0 in 2025.
- Business Quant data shows RAPH's Current Assets at $51000.0 in Q4 2025, $5000.0 in Q3 2025, and $28000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.05 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.71 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 6.47 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 19.71 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 2.87 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 53.60 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 10.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.44 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.58 Bn |
| 10 | Raphael Pharmaceutical | 27.37 Mn | 27.33 Mn | - | 51,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 51,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Jun 30, 2025 | 28,000.00 |
| Mar 31, 2025 | 91,000.00 |
| Dec 31, 2024 | 25,000.00 |
| Sep 30, 2024 | 49,000.00 |
| Jun 30, 2024 | 126,000.00 |
| Mar 31, 2024 | 350,000.00 |
| Dec 31, 2023 | 237,000.00 |
| Sep 30, 2023 | 402,000.00 |
| Jun 30, 2023 | 118,000.00 |
| Mar 31, 2023 | 149,000.00 |
| Dec 31, 2022 | 331,000.00 |
| Sep 30, 2022 | 119,000.00 |
| Jun 30, 2022 | 196,000.00 |
| Mar 31, 2022 | 180,000.00 |
| Dec 31, 2021 | 422,000.00 |
| Sep 30, 2021 | 62,000.00 |
| Dec 31, 2020 | 323,000.00 |